For patients with esophageal tumors, it is generally considered that they need to undergo active treatment through two or three incisions or surgical treatment. The cost of radical treatment in a third-grade hospital generally does not exceed 30,000 yuan. If the patient’s residence is in coastal cities in the eastern region or economically developed areas, or the hospital level of the hospital for treatment is higher, then the cost may be higher. In addition, patients need to pay attention to undergoing partial radiotherapy and chemotherapy or radiotherapy and chemotherapy after surgery, and regularly follow up with CT and PET-CT examination when necessary.

The selection of treatment methods for esophageal malignant tumors is related to the location of the tumor, the clinical stage, and the patient’s condition. For upper esophageal malignant tumors, radical surgery, tumor radiotherapy, and adjuvant radiotherapy and chemotherapy methods are recommended, and targeted therapy drugs can be added when necessary. For middle and lower esophageal malignant tumors, if the clinical stage is early, within stage II, surgical tumor resection and lymph node dissection should be recommended, and postoperative treatment measures should be decided according to the pathological examination results, including adjuvant radiotherapy and chemotherapy, tumor radiotherapy, and targeted therapy drug treatment. For patients with poor health conditions, palliative treatment is recommended, with partial tumor radiotherapy given to improve the symptoms and extend the survival time of the patients.

Esophageal tumors are divided into benign tumors and malignant tumors according to their characteristics. The most common benign tumors of the esophagus are leiomyomas and mesenchymal tumors. According to the size, origin, depth, and characteristics of the disease, different treatment measures should be adopted. For example, if the disease is relatively small and the origin is relatively deep, and the endoscopy observation meets the conditions of benign disease, regular follow-up can be performed, and endoscopic resection or surgical treatment can be performed when necessary. For malignant tumors of the esophagus, that is, esophageal cancer, the treatment methods chosen vary greatly according to the actual stage. If the diameter of the disease is less than 2 cm or below the range of esophageal self-perceived electromotive force, and the invasion depth is relatively shallow, and it has not reached the submucosal layer of the esophagus, endoscopic mucosal resection can be performed.

For early-stage esophageal cancer patients, surgical treatment methods can be chosen. Esophageal cancer is relatively sensitive to radiotherapy and chemotherapy, and radiotherapy and chemotherapy can also be chosen. There are also radiotherapy and chemotherapy, generally used for terminal patients who cannot undergo surgery or radiotherapy and chemotherapy. The efficacy of radiotherapy and chemotherapy is not very satisfactory, but for the prevention and treatment of systemic metastasis of esophageal cancer, radiotherapy and chemotherapy are currently the only accurate and reasonable method. In addition, there are also some comprehensive treatment plans, mainly including four methods, including preoperative or postoperative radiotherapy and chemotherapy, surgery after radiotherapy and chemotherapy, surgery after radiotherapy and chemotherapy plus radiotherapy, and radiotherapy and chemotherapy plus radiotherapy and chemotherapy. Therefore, each patient’s condition is different, and treatment plans should be formulated according to the actual situation.